NCT04732975View on ClinicalTrials.gov

Mason Heart Study With MCG

SuspendedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Acute Myocardial Injuries

Interventions

DEVICE

CardioFlux

Non-invasive screening for ACS

Trial Locations (1)

45040

Genetesis Facility, Mason

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Genetesis Inc.

INDUSTRY

NCT04732975 - Mason Heart Study With MCG | Biotech Hunter | Biotech Hunter